zincov has been researched along with amastatin in 2 studies
| Studies (zincov) | Trials (zincov) | Recent Studies (post-2010) (zincov) | Studies (amastatin) | Trials (amastatin) | Recent Studies (post-2010) (amastatin) |
|---|---|---|---|---|---|
| 9 | 0 | 0 | 183 | 0 | 19 |
| Protein | Taxonomy | zincov (IC50) | amastatin (IC50) |
|---|---|---|---|
| Aminopeptidase N | Sus scrofa (pig) | 1.1 | |
| Angiotensin-converting enzyme | Rattus norvegicus (Norway rat) | 1.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moore, WM; Spilburg, CA | 1 |
| LePard, KJ; Mohammed, JR; Stephens, RL; Ward, PE | 1 |
2 other study(ies) available for zincov and amastatin
| Article | Year |
|---|---|
Peptide hydroxamic acids inhibit skin collagenase.
Topics: Anti-Bacterial Agents; Captopril; Endopeptidases; Fibroblasts; Humans; Hydroxamic Acids; Metalloendopeptidases; Microbial Collagenase; Oligopeptides; Peptides; Protease Inhibitors; Skin | 1986 |
Intracisternal neutral endopeptidase-24.11 inhibitors produce inhibition in gastric acid output: independence from opiate, bombesin, or neurotensin-mediated mechanisms.
Topics: Animals; Anti-Bacterial Agents; Drug Interactions; Gastric Acid; Gastrointestinal Hormones; Glycopeptides; Hydroxamic Acids; Injections, Intravenous; Injections, Intraventricular; Male; Naloxone; Neprilysin; Oligopeptides; Peptides; Rats; Rats, Sprague-Dawley; Reserpine | 1993 |